Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Bertrand Cariou
Based on 12 articles published since 2009
(Why 12 articles?)
||||
Expertise Level
The expertise of Bertrand Cariou ranks in the
  • Top 0.21%
  • ... of 27,574 published authors worldwide on Hypercholesterolemia
  • ... from 2009 through 2019
  • ... based on contributions to 12 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Cariou, B   ·   Cariou, Bertrand
Work Locations
Details
Most likely:    Universite de Nantes      
2018
  • Department of Vascular Medicine, Academisch Medisch Centrum, Amsterdam, Netherlands. · Inserm UMR 1188 DéTROI, Université de La Réunion, Saint-Denis de La Réunion, France. · L'institut du thorax, INSERM, CNRS, Université de Nantes, CHU Nantes, Nantes, France. · Department of Vascular Medicine, Academisch Medisch Centrum, Amsterdam, Netherlands. · Pubmed 30367179
  • 1 Fundación Jiménez Díaz, Autónoma University and CiberCV, Madrid, Spain. · 2 Karolinska University Hospital, Stockholm, Sweden. · 3 Karolinska Institutet, Stockholm, Sweden. · 4 Cardiovascular Sciences Institute (ICCC) and CiberCV, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · 5 University of Geneva, Switzerland. · 6 L'Institut du Thorax, INSERM, CNRS, UNIV Nantes, CHU Nantes, France. · 7 Academic Medical Centre, Amsterdam, The Netherlands. · 8 Fundación Jiménez Díaz, Autónoma University and CIBERDEM, Madrid, Spain. · 9 University of Sheffield, UK. · 10 University of Amsterdam, The Netherlands. · 11 Institute for Cardiovascular Prevention, LMU Munich and German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Germany. · 12 University Heart Centre, University Hospital Zurich and Centre for Molecular Cardiology, University of Zurich, Switzerland. · 13 Kennedy Institute, NDORMS, University of Oxford, UK. · 14 INSERM UMR-1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France. · 15 Cardiovascular Research Institute Maastricht, Maastricht University, The Netherlands. · 16 University Medical Centre Utrecht, Netherlands. · Pubmed 29759006
  • Li Ka Shing Knowledge Institute of St Michael's Hospital, University of Toronto, Ontario, Canada. · Department of Internal Medicine I, University Hospital RWTH Aachen, Aachen, Germany. · Sanofi, Montpellier, France. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA. · Institut du Thorax, CHU Nantes, Nantes, France. · Pubmed 28799203
2017
  • Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. · Department of Endocrinology, l'institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, Nantes, France. · Department of Internal Medicine I, University Hospital RWTH Aachen, Aachen, Germany. · University of Edinburgh, Edinburgh, UK. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Hospital Virgen de la Victoria, CIBERobn, Málaga University, Málaga, Spain. · Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK. · Sanofi, Paris, France. · Sanofi, Gentilly, France. · Sanofi, Chilly-Mazarin, France. · IviData Stats, Levallois-Perret, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · University of California San Diego School of Medicine, and Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, California. · Pubmed 28905478
  • Cardiovascular Center of Sarasota, Sarasota, Florida. Electronic address: · Harvard Clinical Research Institute, Boston, Massachusetts. · Division of Lipidology, Department of Medicine, University of Cape Town and MRC Cape Heart Group, Cape Town, South Africa. · Virginia Commonwealth University and National Clinical Research, Inc., Richmond, Virginia. · L'Institut du Thorax, CHU de Nantes, Nantes, France. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · Sanofi, Bridgewater, New Jersey. · University of Edinburgh, Edinburgh, UK. · Pubmed 28750828
  • Institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, 44093 Nantes cedex 1, France. Electronic address: · Li KaShing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. · Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany. · IVIDATA, 92300 Levallois-Perret, France. · University of Edinburgh, Edinburgh, Scotland, UK. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · University of California San Diego School of Medicine, Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, CA, USA. · CIBERobn, Hospital Virgen de la Victoria, Málaga University, Spain. · Sanofi, 91380 Chilly-Mazarin, France. · Sanofi, Bridgewater, NJ, USA. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Department of Primary Care and Public Health, School of Public Health, Imperial College, London, UK. · Sanofi, 75008 Paris, France. · Pubmed 28347654
2016
  • University of Edinburgh, Edinburgh, UK · Columbia University, New York, NY, USA. · University of Iowa, Iowa City, IA, USA. · Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. · University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen University, Aachen, Germany. · University of California San Diego School of Medicine, La Jolla, CA, USA. · Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, CA, USA. · CHU Nantes, Institut du Thorax, France. · Sanofi, Montpellier, France. · Regeneron Pharmaceuticals, Tarrytown, NY, USA. · Sanofi, Paris, France. · University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. · Pubmed 27460890
2015
  • The Sterling Research Group and University of Cincinnati, Cincinnati, Ohio. Electronic address: · Sanofi, Paris, France. · Regeneron Pharmaceuticals, Inc, Tarrytown, New York. · Department of Endocrinology, l'Institut du Thorax, Nantes University Hospital, Nantes, France. · Pubmed 26278513
  • Harvard Clinical Research Institute, 930 W. Commonwealth Ave, Boston, MA 02215, USA · Department of Endocrinology, L'Institut du Thorax, CHU de Nantes, Nantes, France. · Division of Lipidology, Department of Medicine, University of Cape Town and MRC Cape Heart Group, Cape Town, South Africa. · Virginia Commonwealth University and National Clinical Research, Inc., Richmond, VA, USA. · Sanofi, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Sanofi, Bridgewater, NJ, USA. · University of Dundee, Dundee, UK. · Pubmed 25687353
2011
  • INSERM, UMR915, L'Institut du Thorax, F-44000 Nantes, France. · Pubmed 21596380
  • Clinique d'endocrinologie, hôpital Guillaume-et-René-Laennec, CHU de Nantes, 44093 Saint-Herblain Cedex 1. · Pubmed 22135977
Probable:    INSERM France      
2018
  • Department of Vascular Medicine, Academisch Medisch Centrum, Amsterdam, Netherlands. · Inserm UMR 1188 DéTROI, Université de La Réunion, Saint-Denis de La Réunion, France. · L'institut du thorax, INSERM, CNRS, Université de Nantes, CHU Nantes, Nantes, France. · Department of Vascular Medicine, Academisch Medisch Centrum, Amsterdam, Netherlands. · Pubmed 30367179
  • 1 Fundación Jiménez Díaz, Autónoma University and CiberCV, Madrid, Spain. · 2 Karolinska University Hospital, Stockholm, Sweden. · 3 Karolinska Institutet, Stockholm, Sweden. · 4 Cardiovascular Sciences Institute (ICCC) and CiberCV, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · 5 University of Geneva, Switzerland. · 6 L'Institut du Thorax, INSERM, CNRS, UNIV Nantes, CHU Nantes, France. · 7 Academic Medical Centre, Amsterdam, The Netherlands. · 8 Fundación Jiménez Díaz, Autónoma University and CIBERDEM, Madrid, Spain. · 9 University of Sheffield, UK. · 10 University of Amsterdam, The Netherlands. · 11 Institute for Cardiovascular Prevention, LMU Munich and German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Germany. · 12 University Heart Centre, University Hospital Zurich and Centre for Molecular Cardiology, University of Zurich, Switzerland. · 13 Kennedy Institute, NDORMS, University of Oxford, UK. · 14 INSERM UMR-1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France. · 15 Cardiovascular Research Institute Maastricht, Maastricht University, The Netherlands. · 16 University Medical Centre Utrecht, Netherlands. · Pubmed 29759006
2017
  • Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. · Department of Endocrinology, l'institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, Nantes, France. · Department of Internal Medicine I, University Hospital RWTH Aachen, Aachen, Germany. · University of Edinburgh, Edinburgh, UK. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Hospital Virgen de la Victoria, CIBERobn, Málaga University, Málaga, Spain. · Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK. · Sanofi, Paris, France. · Sanofi, Gentilly, France. · Sanofi, Chilly-Mazarin, France. · IviData Stats, Levallois-Perret, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · University of California San Diego School of Medicine, and Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, California. · Pubmed 28905478
  • Institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, 44093 Nantes cedex 1, France. Electronic address: · Li KaShing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. · Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany. · IVIDATA, 92300 Levallois-Perret, France. · University of Edinburgh, Edinburgh, Scotland, UK. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · University of California San Diego School of Medicine, Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, CA, USA. · CIBERobn, Hospital Virgen de la Victoria, Málaga University, Spain. · Sanofi, 91380 Chilly-Mazarin, France. · Sanofi, Bridgewater, NJ, USA. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Department of Primary Care and Public Health, School of Public Health, Imperial College, London, UK. · Sanofi, 75008 Paris, France. · Pubmed 28347654
2011
  • INSERM, UMR915, L'Institut du Thorax, F-44000 Nantes, France. · Pubmed 21596380
Probable:    Centre National de la Recherche Scientifique      
2018
  • Department of Vascular Medicine, Academisch Medisch Centrum, Amsterdam, Netherlands. · Inserm UMR 1188 DéTROI, Université de La Réunion, Saint-Denis de La Réunion, France. · L'institut du thorax, INSERM, CNRS, Université de Nantes, CHU Nantes, Nantes, France. · Department of Vascular Medicine, Academisch Medisch Centrum, Amsterdam, Netherlands. · Pubmed 30367179
  • 1 Fundación Jiménez Díaz, Autónoma University and CiberCV, Madrid, Spain. · 2 Karolinska University Hospital, Stockholm, Sweden. · 3 Karolinska Institutet, Stockholm, Sweden. · 4 Cardiovascular Sciences Institute (ICCC) and CiberCV, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · 5 University of Geneva, Switzerland. · 6 L'Institut du Thorax, INSERM, CNRS, UNIV Nantes, CHU Nantes, France. · 7 Academic Medical Centre, Amsterdam, The Netherlands. · 8 Fundación Jiménez Díaz, Autónoma University and CIBERDEM, Madrid, Spain. · 9 University of Sheffield, UK. · 10 University of Amsterdam, The Netherlands. · 11 Institute for Cardiovascular Prevention, LMU Munich and German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Germany. · 12 University Heart Centre, University Hospital Zurich and Centre for Molecular Cardiology, University of Zurich, Switzerland. · 13 Kennedy Institute, NDORMS, University of Oxford, UK. · 14 INSERM UMR-1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France. · 15 Cardiovascular Research Institute Maastricht, Maastricht University, The Netherlands. · 16 University Medical Centre Utrecht, Netherlands. · Pubmed 29759006
2017
  • Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. · Department of Endocrinology, l'institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, Nantes, France. · Department of Internal Medicine I, University Hospital RWTH Aachen, Aachen, Germany. · University of Edinburgh, Edinburgh, UK. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Hospital Virgen de la Victoria, CIBERobn, Málaga University, Málaga, Spain. · Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK. · Sanofi, Paris, France. · Sanofi, Gentilly, France. · Sanofi, Chilly-Mazarin, France. · IviData Stats, Levallois-Perret, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · University of California San Diego School of Medicine, and Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, California. · Pubmed 28905478
  • Institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, 44093 Nantes cedex 1, France. Electronic address: · Li KaShing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. · Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany. · IVIDATA, 92300 Levallois-Perret, France. · University of Edinburgh, Edinburgh, Scotland, UK. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · University of California San Diego School of Medicine, Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, CA, USA. · CIBERobn, Hospital Virgen de la Victoria, Málaga University, Spain. · Sanofi, 91380 Chilly-Mazarin, France. · Sanofi, Bridgewater, NJ, USA. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Department of Primary Care and Public Health, School of Public Health, Imperial College, London, UK. · Sanofi, 75008 Paris, France. · Pubmed 28347654
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 12 total) written by Bertrand Cariou about Hypercholesterolemia:

  • Inhibiting PCSK9 - biology beyond LDL control. 2018
  • Interplay between hypercholesterolaemia and inflammation in atherosclerosis: Translating experimental targets into clinical practice. 2018
  • Efficacy and safety of alirocumab in people with prediabetes vs those with normoglycaemia at baseline: a pooled analysis of 10 phase III ODYSSEY clinical trials. 2018
  • Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM-INSULIN randomized trial. 2017
  • Efficacy and Safety of Alirocumab Versus Ezetimibe Over 2 Years (from ODYSSEY COMBO II). 2017
  • Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM-INSULIN trial. 2017
  • No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies. 2016
  • Patient and Physician Perspectives on Mode of Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C Levels. 2015
  • Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial. 2015
  • Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins: rationale and design of the ODYSSEY COMBO I and II trials. 2014
Show List of Full Article Records
Google Searches

Learn more about Bertrand Cariou using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Universite de Nantes
INSERM France
Centre National de la Recherche Scientifique
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Universite de Nantes
2018
  • Department of Vascular Medicine, Academisch Medisch Centrum, Amsterdam, Netherlands. · Inserm UMR 1188 DéTROI, Université de La Réunion, Saint-Denis de La Réunion, France. · L'institut du thorax, INSERM, CNRS, Université de Nantes, CHU Nantes, Nantes, France. · Department of Vascular Medicine, Academisch Medisch Centrum, Amsterdam, Netherlands. · Pubmed 30367179
  • 1 Fundación Jiménez Díaz, Autónoma University and CiberCV, Madrid, Spain. · 2 Karolinska University Hospital, Stockholm, Sweden. · 3 Karolinska Institutet, Stockholm, Sweden. · 4 Cardiovascular Sciences Institute (ICCC) and CiberCV, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · 5 University of Geneva, Switzerland. · 6 L'Institut du Thorax, INSERM, CNRS, UNIV Nantes, CHU Nantes, France. · 7 Academic Medical Centre, Amsterdam, The Netherlands. · 8 Fundación Jiménez Díaz, Autónoma University and CIBERDEM, Madrid, Spain. · 9 University of Sheffield, UK. · 10 University of Amsterdam, The Netherlands. · 11 Institute for Cardiovascular Prevention, LMU Munich and German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Germany. · 12 University Heart Centre, University Hospital Zurich and Centre for Molecular Cardiology, University of Zurich, Switzerland. · 13 Kennedy Institute, NDORMS, University of Oxford, UK. · 14 INSERM UMR-1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France. · 15 Cardiovascular Research Institute Maastricht, Maastricht University, The Netherlands. · 16 University Medical Centre Utrecht, Netherlands. · Pubmed 29759006
  • Li Ka Shing Knowledge Institute of St Michael's Hospital, University of Toronto, Ontario, Canada. · Department of Internal Medicine I, University Hospital RWTH Aachen, Aachen, Germany. · Sanofi, Montpellier, France. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA. · Institut du Thorax, CHU Nantes, Nantes, France. · Pubmed 28799203
2017
  • Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. · Department of Endocrinology, l'institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, Nantes, France. · Department of Internal Medicine I, University Hospital RWTH Aachen, Aachen, Germany. · University of Edinburgh, Edinburgh, UK. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Hospital Virgen de la Victoria, CIBERobn, Málaga University, Málaga, Spain. · Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK. · Sanofi, Paris, France. · Sanofi, Gentilly, France. · Sanofi, Chilly-Mazarin, France. · IviData Stats, Levallois-Perret, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · University of California San Diego School of Medicine, and Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, California. · Pubmed 28905478
  • Cardiovascular Center of Sarasota, Sarasota, Florida. Electronic address: · Harvard Clinical Research Institute, Boston, Massachusetts. · Division of Lipidology, Department of Medicine, University of Cape Town and MRC Cape Heart Group, Cape Town, South Africa. · Virginia Commonwealth University and National Clinical Research, Inc., Richmond, Virginia. · L'Institut du Thorax, CHU de Nantes, Nantes, France. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · Sanofi, Bridgewater, New Jersey. · University of Edinburgh, Edinburgh, UK. · Pubmed 28750828
  • Institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, 44093 Nantes cedex 1, France. Electronic address: · Li KaShing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. · Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany. · IVIDATA, 92300 Levallois-Perret, France. · University of Edinburgh, Edinburgh, Scotland, UK. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · University of California San Diego School of Medicine, Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, CA, USA. · CIBERobn, Hospital Virgen de la Victoria, Málaga University, Spain. · Sanofi, 91380 Chilly-Mazarin, France. · Sanofi, Bridgewater, NJ, USA. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Department of Primary Care and Public Health, School of Public Health, Imperial College, London, UK. · Sanofi, 75008 Paris, France. · Pubmed 28347654
2016
  • University of Edinburgh, Edinburgh, UK · Columbia University, New York, NY, USA. · University of Iowa, Iowa City, IA, USA. · Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. · University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen University, Aachen, Germany. · University of California San Diego School of Medicine, La Jolla, CA, USA. · Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, CA, USA. · CHU Nantes, Institut du Thorax, France. · Sanofi, Montpellier, France. · Regeneron Pharmaceuticals, Tarrytown, NY, USA. · Sanofi, Paris, France. · University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. · Pubmed 27460890
2015
  • The Sterling Research Group and University of Cincinnati, Cincinnati, Ohio. Electronic address: · Sanofi, Paris, France. · Regeneron Pharmaceuticals, Inc, Tarrytown, New York. · Department of Endocrinology, l'Institut du Thorax, Nantes University Hospital, Nantes, France. · Pubmed 26278513
  • Harvard Clinical Research Institute, 930 W. Commonwealth Ave, Boston, MA 02215, USA · Department of Endocrinology, L'Institut du Thorax, CHU de Nantes, Nantes, France. · Division of Lipidology, Department of Medicine, University of Cape Town and MRC Cape Heart Group, Cape Town, South Africa. · Virginia Commonwealth University and National Clinical Research, Inc., Richmond, VA, USA. · Sanofi, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Sanofi, Bridgewater, NJ, USA. · University of Dundee, Dundee, UK. · Pubmed 25687353
2011
  • INSERM, UMR915, L'Institut du Thorax, F-44000 Nantes, France. · Pubmed 21596380
  • Clinique d'endocrinologie, hôpital Guillaume-et-René-Laennec, CHU de Nantes, 44093 Saint-Herblain Cedex 1. · Pubmed 22135977
INSERM France
2018
  • Department of Vascular Medicine, Academisch Medisch Centrum, Amsterdam, Netherlands. · Inserm UMR 1188 DéTROI, Université de La Réunion, Saint-Denis de La Réunion, France. · L'institut du thorax, INSERM, CNRS, Université de Nantes, CHU Nantes, Nantes, France. · Department of Vascular Medicine, Academisch Medisch Centrum, Amsterdam, Netherlands. · Pubmed 30367179
  • 1 Fundación Jiménez Díaz, Autónoma University and CiberCV, Madrid, Spain. · 2 Karolinska University Hospital, Stockholm, Sweden. · 3 Karolinska Institutet, Stockholm, Sweden. · 4 Cardiovascular Sciences Institute (ICCC) and CiberCV, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · 5 University of Geneva, Switzerland. · 6 L'Institut du Thorax, INSERM, CNRS, UNIV Nantes, CHU Nantes, France. · 7 Academic Medical Centre, Amsterdam, The Netherlands. · 8 Fundación Jiménez Díaz, Autónoma University and CIBERDEM, Madrid, Spain. · 9 University of Sheffield, UK. · 10 University of Amsterdam, The Netherlands. · 11 Institute for Cardiovascular Prevention, LMU Munich and German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Germany. · 12 University Heart Centre, University Hospital Zurich and Centre for Molecular Cardiology, University of Zurich, Switzerland. · 13 Kennedy Institute, NDORMS, University of Oxford, UK. · 14 INSERM UMR-1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France. · 15 Cardiovascular Research Institute Maastricht, Maastricht University, The Netherlands. · 16 University Medical Centre Utrecht, Netherlands. · Pubmed 29759006
2017
  • Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. · Department of Endocrinology, l'institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, Nantes, France. · Department of Internal Medicine I, University Hospital RWTH Aachen, Aachen, Germany. · University of Edinburgh, Edinburgh, UK. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Hospital Virgen de la Victoria, CIBERobn, Málaga University, Málaga, Spain. · Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK. · Sanofi, Paris, France. · Sanofi, Gentilly, France. · Sanofi, Chilly-Mazarin, France. · IviData Stats, Levallois-Perret, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · University of California San Diego School of Medicine, and Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, California. · Pubmed 28905478
  • Institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, 44093 Nantes cedex 1, France. Electronic address: · Li KaShing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. · Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany. · IVIDATA, 92300 Levallois-Perret, France. · University of Edinburgh, Edinburgh, Scotland, UK. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · University of California San Diego School of Medicine, Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, CA, USA. · CIBERobn, Hospital Virgen de la Victoria, Málaga University, Spain. · Sanofi, 91380 Chilly-Mazarin, France. · Sanofi, Bridgewater, NJ, USA. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Department of Primary Care and Public Health, School of Public Health, Imperial College, London, UK. · Sanofi, 75008 Paris, France. · Pubmed 28347654
2011
  • INSERM, UMR915, L'Institut du Thorax, F-44000 Nantes, France. · Pubmed 21596380
Centre National de la Recherche Scientifique
2018
  • Department of Vascular Medicine, Academisch Medisch Centrum, Amsterdam, Netherlands. · Inserm UMR 1188 DéTROI, Université de La Réunion, Saint-Denis de La Réunion, France. · L'institut du thorax, INSERM, CNRS, Université de Nantes, CHU Nantes, Nantes, France. · Department of Vascular Medicine, Academisch Medisch Centrum, Amsterdam, Netherlands. · Pubmed 30367179
  • 1 Fundación Jiménez Díaz, Autónoma University and CiberCV, Madrid, Spain. · 2 Karolinska University Hospital, Stockholm, Sweden. · 3 Karolinska Institutet, Stockholm, Sweden. · 4 Cardiovascular Sciences Institute (ICCC) and CiberCV, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · 5 University of Geneva, Switzerland. · 6 L'Institut du Thorax, INSERM, CNRS, UNIV Nantes, CHU Nantes, France. · 7 Academic Medical Centre, Amsterdam, The Netherlands. · 8 Fundación Jiménez Díaz, Autónoma University and CIBERDEM, Madrid, Spain. · 9 University of Sheffield, UK. · 10 University of Amsterdam, The Netherlands. · 11 Institute for Cardiovascular Prevention, LMU Munich and German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Germany. · 12 University Heart Centre, University Hospital Zurich and Centre for Molecular Cardiology, University of Zurich, Switzerland. · 13 Kennedy Institute, NDORMS, University of Oxford, UK. · 14 INSERM UMR-1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France. · 15 Cardiovascular Research Institute Maastricht, Maastricht University, The Netherlands. · 16 University Medical Centre Utrecht, Netherlands. · Pubmed 29759006
2017
  • Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. · Department of Endocrinology, l'institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, Nantes, France. · Department of Internal Medicine I, University Hospital RWTH Aachen, Aachen, Germany. · University of Edinburgh, Edinburgh, UK. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Hospital Virgen de la Victoria, CIBERobn, Málaga University, Málaga, Spain. · Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK. · Sanofi, Paris, France. · Sanofi, Gentilly, France. · Sanofi, Chilly-Mazarin, France. · IviData Stats, Levallois-Perret, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · University of California San Diego School of Medicine, and Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, California. · Pubmed 28905478
  • Institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, 44093 Nantes cedex 1, France. Electronic address: · Li KaShing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. · Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany. · IVIDATA, 92300 Levallois-Perret, France. · University of Edinburgh, Edinburgh, Scotland, UK. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · University of California San Diego School of Medicine, Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, CA, USA. · CIBERobn, Hospital Virgen de la Victoria, Málaga University, Spain. · Sanofi, 91380 Chilly-Mazarin, France. · Sanofi, Bridgewater, NJ, USA. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Department of Primary Care and Public Health, School of Public Health, Imperial College, London, UK. · Sanofi, 75008 Paris, France. · Pubmed 28347654
University of Dundee
2014
University of Chester
2014
Yearly article counts 03312100200
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.